Abstract
Non-aneurysmal perimesencephalic subarachnoid hemorrhage makes around 5% of subarachnoid hemorrhage which in turn represents approximately 5% of all strokes. Perimesencephalic subarachnoid hemorrhage etiology is usually unknown. In this case report, non-traumatic non-aneurysmal perimesencephalic subarachnoid hemorrhage as a primary presenting manifestation of acute myeloid leukemia is presented. Fifty-year-old female patient presented with severe headache never experienced before associated with photophobia and neck stiffness. Computed tomography revealed subarachnoid hemorrhage within the perimesencephalic region, and cerebral angiography was normal. Labs were suggestive of hematological malignancy that was confirmed as acute myeloid leukemia by bone marrow biopsy. Hematological malignancies ought to be kept in mind in any non-traumatic non-aneurysmal subarachnoid hemorrhage.
Similar content being viewed by others
Data Availability
The corresponding author takes full responsibility for the data, has full access to all of the data, and has the right to publish any and all data separate and apart from any sponsor.
Code Availability
Not applicable.
Abbreviations
- ICH :
-
Intracranial hemorrhage
- SAH :
-
Subarachnoid hemorrhage
- CT :
-
Computed tomography
- CTA :
-
Cerebral computed tomography
- MRV :
-
Magnetic resonance venography
- CBC :
-
Complete blood count
- PMNs :
-
Polymorphonuclear leukocytes
- AML :
-
Acute myeloid leukemia
- NAPSAH :
-
Non-aneurysmal perimesencephalic subarachnoid hemorrhage
- DSA :
-
Digital subtraction angiography
References
An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke. 2017;19(1):3–10. https://doi.org/10.5853/jos.2016.00864.
Chen CY, Tai CH, Cheng A, Wu HC, Tsay W, Liu JH, et al. Intracranial hemorrhage in adult patients with hematological malignancies. BMC Med. 2012;10:97. https://doi.org/10.1186/1741-7015-10-97.
El-Hajj M, Salameh P, Rachidi S, Hosseini H. The epidemiology of stroke in the Middle East. Eur Stroke J. 2016;1(3):180–98. https://doi.org/10.1177/2396987316654338.
El-Tallawy HN, Farghaly WM, Shehata GA, Abdel-Hakeem NM, Rageh TA, Badry R, Kandil MR. Epidemiology of non-fatal cerebrovascular stroke and transient ischemic attacks in Al Quseir. Egypt Clin Interv Aging. 2013;8:1547–51. https://doi.org/10.2147/CIA.S48785.
Ziu E, Mesfin FB. Subarachnoid hemorrhage. [Updated 2021 Aug 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441958/.
Hou K, Yu J. Current status of perimesencephalic non-aneurysmal subarachnoid hemorrhage. Front Neurol. 2022;13:960702. https://doi.org/10.3389/fneur.2022.960702.
Rinkel GJ, Wijdicks EF, Vermeulen M, Ramos LM, Tanghe HL, Hasan D, et al. Nonaneurysmal perimesencephalic subarachnoid hemorrhage: CT and MR patterns that differ from aneurysmal rupture. AJNR Am J Neuroradiol. 1991;12:829–34.
Wallace AN, Vyhmeister R, Dines JN, Chatterjee AR, Kansagra AP, Viets R, et al. Evaluation of an anatomic definition of non-aneurysmal perimesencephalic subarachnhoid hemorrhage. J Neurointerv Surg. 2016;8:378–85. https://doi.org/10.1136/neurintsurg-2015-011680.
Ferro JM, Infante J. Cerebrovascular manifestations in hematological diseases: an update. J Neurol. 2021;268:3480–92. https://doi.org/10.1007/s00415-021-10441-9.
Chen S, Zhang J, Lu X, Cen G, Song Y, Deng X, et al. Cancer related subarachnoid hemorrhage: a multicenter retrospective study using propensity score matching analysis. Front Cell Neurosci. 2022;16:813084. https://doi.org/10.3389/fncel.2022.813084.
Maher M, Schweizer TA, Macdonald RL. Treatment of spontaneous subarachnoid hemorrhage: guidelines and gaps. Stroke. 2020;51(4):1326–32. https://doi.org/10.1161/STROKEAHA.119.025997.
Adams HP Jr. Cancer and cerebrovascular disease. Curr Neurol Neurosci Rep. 2019;19(10):73. https://doi.org/10.1007/s11910-019-0985-0.
Velander AJ, DeAngelis LM, Navi BB. Intracranial hemorrhage in patients with cancer. Curr Atheroscler Rep. 2012;14(4):373–81. https://doi.org/10.1007/s11883-012-0250-3.
Rinkel GJ, Wijdicks EF, Vermeulen M, Ramos LM, Tanghe HL, Hasan D, et al. Nonaneurysmal perimesencephalic subarachnoid hemorrhage: CT and MR patterns that differ from aneurysmal rupture. AJNR Am J Neuroradiol. 1991;12(5):829–34.
Bhatia KD, Kortman H, Wälchli T, Radovanovic I, Pereira VM, Krings T. Artery of Davidoff and Schechter supply in dural arteriovenous fistulas. AJNR Am J Neuroradiol. 2020;41(2):300–4. https://doi.org/10.3174/ajnr.A6380.
Kapadia A, Schweizer TA, Spears J, Cusimano M, Macdonald RL. Nonaneurysmal perimesencephalic subarachnoid hemorrhage: diagnosis, pathophysiology, clinical characteristics, and long-term outcome. World Neurosurg. 2014;82(6):1131–43. https://doi.org/10.1016/j.wneu.2014.07.006.
Agid R, Andersson T, Almqvist H, Willinsky RA, Lee SK, terBrugge KG, et al. Negative CT angiography findings in patients with spontaneous subarachnoid hemorrhage: when is digital subtraction angiography still needed? AJNR Am J Neuroradiol. 2010;31(4):696–705. https://doi.org/10.3174/ajnr.A1884.
Cruz JP, Sarma D, Noel de Tilly L. Perimesencephalic subarachnoid hemorrhage: when to stop imaging? Emerg Radiol. 2011;18(3):197–202. https://doi.org/10.1007/s10140-011-0939-6.
Ruigrok YM, Rinkel GJ, Buskens E, Velthuis BK, van Gijn J. Perimesencephalic hemorrhage and CT angiography: a decision analysis. Stroke. 2000;31(12):2976–83. https://doi.org/10.1161/01.str.31.12.2976.
Balmages A, Dinglasan J, Osborn MB. Severe intracranial hemorrhage at initial presentation of acute myelogenous leukemia. Clin Pract Cases Emerg Med. 2018;2(3):203–6. https://doi.org/10.5811/cpcem.2018.4.37881.
Wu MY, Lin CH, Hou YT, Lin PC, Yiang GT, Tien YC, et al. Syncope as initial presentation in an undifferentiated type acute myeloid leukemia patient with acute intracranial hemorrhage. Brain Sci. 2019;9(8):207. https://doi.org/10.3390/brainsci9080207.
Author information
Authors and Affiliations
Contributions
“Author have read and approved the manuscript”
TR: concept behind the work, drafting and revising the manuscript, collecting and supervising the case medical history and investigations, AE: supervising the case medical history and investigations, revising the manuscript, AZ: drafting and revising the manuscript, collecting and supervising the case medical history and investigations.
Corresponding author
Ethics declarations
Ethics Approval
All procedures performed in the study were in accordance with the ethical standards of the Faculty of Medicine, Ain Shams University Research and Ethical Committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Consent to Participate
An informal written consent was obtained from the patient to participate in the current case report.
Consent for Publication
Written informed consent was obtained from participant for publication of this case report and accompanying images.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Medicine
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Roushdy, T., Elbassiouny, A. & Zaki, A.S. Non-Traumatic Non-Aneurysmal Perimesencephalic Subarachnoid Hemorrhage as a Primary Presentation of Acute Myeloid Leukemia: an Uncommon Case Report. SN Compr. Clin. Med. 4, 248 (2022). https://doi.org/10.1007/s42399-022-01329-4
Accepted:
Published:
DOI: https://doi.org/10.1007/s42399-022-01329-4